| 000 | 00744nam a2200109Ia 4500 | ||
|---|---|---|---|
| 008 | 230817s9999 xx 000 0 und d | ||
| 100 | _aNoemi Muszbek | ||
| 245 | 0 | _aEconomic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs | |
| 650 | _aComputer science, information & general works | ||
| 856 | _uhttps://new.zodml.org/sites/default/files/2023-07/economic_evaluation_of_sarilumab_in_the_treatment_of_adult_patients_with_moderately-to-severely_active_rheumatoid_arthritis_who_have_an_inadequate_response_to_conventional_synthetic_disease-modifying_antirheumatic_dru.pdf | ||
| 942 | _cEBK | ||
| 999 |
_c33476 _d33476 |
||